Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...
CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.
The new Medicare GLP-1 Bridge program, which will allow seniors to get certain GLP-1 drugs for just $50 a month and is part ...
A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...
The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...
Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...
Pharmacists can help answer questions about eligibility requirements, participating medications, prior authorization ...